Cangrelor Prasugrel Transition Study

NCT01852019 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Coronary Artery Disease

Interventions

DRUG: Cangrelor
DRUG: Prasugrel

Sponsor

The Medicines Company